We are hiring!

Strain identifier

BacDive ID: 4969

Type strain: No

Species: Klebsiella pneumoniae

Culture col. no.: CCUG 58866, DSM 789, ATCC 4352, NCIB 10341, WDCM 00192, JCM 20348, CIP 104216, IAM 12015, IFO 13277, NBRC 13277, NCIMB 10341

Strain history: IAM 12015 <-- ATCC 4352 <-- E. C. Robertson ("Escherichia coli subsp. communior").

NCBI tax ID(s): 573 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Klebsiella pneumoniae CCUG 58866 is an aerobe, mesophilic bacterium that was isolated from cow's milk.

  1. aerobe
  2. mesophilic
  3. Bacteria
  4. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #447] Culture collection no. CCUG 58866, DSM 789, ATCC 4352, NCIB 10341, WDCM 00192, JCM 20348, CIP 104216, IAM 12015, IFO 13277, NBRC 13277, NCIMB 10341
    [Ref.: #20218] Associated Passport(s) in StrainInfo 52572, 52569, 52574, 898879
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Phylogeny Corrected identification of a test organism (ATCC 4352) previously thought to be Escherichia coli. Brown CP, Wilson FH Appl Microbiol 10.1128/am.23.3.661-661.1972 1972 *
    Pathogenicity Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino] thiazoles and 5-nonsubstituted/substituted 2-[(4-carbethoxymethylthiazol-2-yl)imino]-4-thiazolidinones. Ates O, Altintas H, Otuk G Arzneimittelforschung 10.1055/s-0031-1300251 2000 *
    Pathogenicity Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities. Kocabalkanli A, Ates O, Otuk G Arch Pharm (Weinheim) 10.1002/1521-4184(200102)334:2<35::aid-ardp35>3.0.co;2-4 2001 *
    Pathogenicity Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Ulusoy N, Gursoy A, Otuk G Farmaco 10.1016/s0014-827x(01)01128-4 2001 *
    Pathogenicity Synthesis and evaluation of antibacterial activity of some 2-[[alpha-(4-substituted benzoyloxy)-alpha-phenylacetyl or methylacetyl]amino]-5-(4-methoxyphenyl)- 1,3,4-oxadiazoles. Kocabalkanli A, Ates O, Otuk G Farmaco 10.1016/s0014-827x(01)01158-2 2001 *
    Pathogenicity Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl]acetic acid ethyl esters. Ates O, Gursoy A, Altintas H, Otuk G, Birteksoz S Arch Pharm (Weinheim) 10.1002/ardp.200390002 2003 *
    Pathogenicity Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities. Ur F, Cesur N, Birteksoz S, Otuk G Arzneimittelforschung 10.1055/s-0031-1296947 2004 *
    Pathogenicity Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives. Koca M, Servi S, Kirilmis C, Ahmedzade M, Kazaz C, Ozbek B, Otuk G Eur J Med Chem 10.1016/j.ejmech.2005.07.004 2005 *
    Pathogenicity Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2- (5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl) imino-4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships. Altintas H, Ates O, Uyde-Dogan BS, Alp FI, Kaleli D, Ozdemir O, Birteksoz S, Otuk G, Atana D, Uzun M Arzneimittelforschung 2006 *
    Pathogenicity Hydroxyapatites and europium(III) doped hydroxyapatites as a carrier of silver nanoparticles and their antimicrobial activity. Wiglusz RJ, Kedziora A, Lukowiak A, Doroszkiewicz W, Strek W J Biomed Nanotechnol 10.1166/jbn.2012.1424 2012 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:


CAPTCHAReload captcha

Change proposal

Successfully sent